Delivery Order SPE2DR25D2218-SPE2DR26FX4D5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,246.76 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10 on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,994.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This competitively awarded, non-set-aside contract is scheduled for completion by January 8, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite...
- The Defense Logistics Agency awarded a $2,995.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This non-set-aside contract, which will be completed by January 7, 2026, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with a ceiling value of $2,820.63 and an ultimate completion date of December 18, 2025. This is a firm fixed-price, non-set-aside delivery order performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 capsules. This competitively awarded, non-set-aside contract has a ceiling value of $2,036.45 with a firm fixed-price structure and an ultimate completion date of January 9, 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $9,683.84 delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10, with completion targeted for December 29, 2025. This competitively awarded, firm fixed price contract utilizes no set-aside designation and calls for performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,368.70 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10s. This is a firm fixed price delivery order with a completion date of January 6, 2026, issued under a non-competitive set-aside arrangement. The products will be sourced from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s). The contract is valued at $14,926.77 with a completion date of January 8, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $4,994.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s). This is a non-set-aside competitive award with an ultimate completion date of January 8, 2026, and performance location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count units) with a firm fixed price ceiling value of $6,048.00. The contract, which is non-set-aside and competitively awarded, is scheduled for ultimate completion by January 5, 2026. AmerisourceBergen will perform the work at its Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DR25D2218Indefinite Delivery Contract
- SPE2DR25D2218-SPE2DR26FX4D5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,336.25 to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is scheduled for completion by January 9, 2026, and performance will be executed from the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities and the Defense Health Agency. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The antiviral medication being procured under this delivery order supports federal medical supply requirements for infectious disease treatment across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/7/26 |